Paul Gonsalves Appointed President of Orthofix: Offers 30 Plus Years of Experience and Proven Leadership

Xenter, Inc. Appoints 4 Industry Leaders to Board of Directors; Closes $12M Series A

Xenter’s first product, which the company will announce shortly, is a medical device that not only combines the function of multiple existing devices but will also revolutionize the field of interventional medicine by producing valuable Physical Intelligence™ data and enabling advanced Artificial Intelligence solutions, leading to improved patient outcomes while reducing the cost, complexity and invasiveness of cardiac procedures.

Indivumed Partners with Oslo University Hospital to Advance Cancer Research

By scanning high-resolution images of haematoxylin and eosin-stained tumor section slides for all IndivuType cases, Indivumed will be able to leverage an entirely new dimension of data in the coming months.

Harold Hill Joins NeuX Technologies as Director of Corporate Accounts

Harold Hill is a retired Special Forces Medic, serving 26 years, and led the medical department for a Special Missions Unit within the United States Special Operations Command

September 14, 2020

Paul Gonsalves has been appointed president of Orthofix, a global medical device company focused on musculoskeletal products and therapies. The news was announced today.

Paul Gonsalves joins Orthofix from Integra LifeSciences, a global provider of regenerative technologies, neurosurgical, and extremity orthopedic solutions, where he served as Chief Commercial Officer.

“Paul brings to Orthofix more than 30 years of industry experience and proven leadership that will both complement and strengthen our exceptional Extremities management team,” said Serbousek. “Throughout his career, Paul has led global teams in the successful development and execution of innovative strategies focused on driving commercial optimization. I am confident his experience and relationships with surgeons and hospitals will enable us to build and accelerate this important area of our business.”

Paul Gonsalves previously served as Senior Vice President, Enterprise Sales and Corporate Marketing at Integra LifeSciences where he led the company’s creation of an enterprise sales organization to expand portfolio contracting. Prior to this, Gonsalves held the position of Senior Vice President and Chief Transformation Officer with AccentCare Inc. Additionally, he served as Vice President and General Manager of Primary Care at Novartis Pharmaceuticals Corporation. Gonsalves was also the Corporate Vice President, Sales Business Process Improvement and Strategic Initiatives for WellCare Health Plans Inc. Early in his career, Gonsalves held various roles of increasing commercial responsibility with GE Healthcare. A Lean Six Sigma Black Belt, he led their global software development program and the sales and service field teams focused on MRI, CT and other diagnostic imaging technologies among other responsibilities.

“It is an honor to be chosen to lead this sector of the company’s business with its long-standing history and reputation as a leader in providing orthopedic extremity solutions to meet the needs of patients around the world,” said Gonsalves. “I look forward to working with the Orthofix Leadership and Extremities teams to continue to grow and expand the availability of these life-changing products.”

Gonsalves holds a B.S. in Management from Rutgers University School of Business in Camden, NJ.



Subscribe to Medical Device News Magazine

Related Articles